Skip to main content
NCBI home page
Heart logoLink to Heart
. 1997 Nov;78(5):475–479. doi: 10.1136/hrt.78.5.475

A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis

P Wilmshurst 1, R Stevenson 1, H Griffiths 1, J Lord 1
PMCID: PMC1892301  PMID: 9415007

Abstract

Objective—To investigate the relation of hyperlipidaemia to calcific aortic valve stenosis.
Design—A case-control study designed to detect a clinically relevant difference in the fasting plasma concentrations of total cholesterol between the groups at the 5% level with a power of 90%. Predefined subgroup analyses were based on presence of significant coronary disease and valve morphology (that is, bicuspid or tricuspid).
Setting—A district general hospital.
Subjects—20 patients with severe calcific aortic stenosis and 20 controls.
Results—Mean (SD) fasting plasma total cholesterol in patients with aortic stenosis was 0.79 (1.50) mmol/l greater than in the controls (p = 0.029). The magnitude of differences between patients with aortic stenosis and controls was similar whether the patients had coronary artery disease (0.78 (1.73) mmol/l) or not (0.80 (1.37) mmol/l). The presence of a stenosed tricuspid aortic valve was associated with a significant increase in plasma cholesterol (1.70 (0.87) mmol/l, p = 0.012). For bicuspid valves the degree of elevation of plasma cholesterol was less and not statistically significant.
Conclusions—Calcific aortic stenosis is associated with hypercholesterolaemia, especially when the valve is tricuspid. Further studies are necessary to confirm that the relation is causal. This finding may have implications for measures to prevent the most common cause of cardiac valve replacement in the developed world.

 Keywords: calcific aortic stenosis;  hypercholesterolaemia;  hyperlipidaemia

Full Text

The Full Text of this article is available as a PDF (103.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davies M. J., Treasure T., Parker D. J. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology. Heart. 1996 Feb;75(2):174–178. doi: 10.1136/hrt.75.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Deutscher S., Rockette H. E., Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis. 1984;37(5):407–415. doi: 10.1016/0021-9681(84)90108-5. [DOI] [PubMed] [Google Scholar]
  3. GORLIN R., GORLIN S. G. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951 Jan;41(1):1–29. doi: 10.1016/0002-8703(51)90002-6. [DOI] [PubMed] [Google Scholar]
  4. Hoagland P. M., Cook E. F., Flatley M., Walker C., Goldman L. Case-control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older). Am J Cardiol. 1985 Mar 1;55(6):744–747. doi: 10.1016/0002-9149(85)90149-3. [DOI] [PubMed] [Google Scholar]
  5. Kannel W. B., Castelli W. P., Gordon T., McNamara P. M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971 Jan;74(1):1–12. doi: 10.7326/0003-4819-74-1-1. [DOI] [PubMed] [Google Scholar]
  6. Kannel W. B., Neaton J. D., Wentworth D., Thomas H. E., Stamler J., Hulley S. B., Kjelsberg M. O. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J. 1986 Oct;112(4):825–836. doi: 10.1016/0002-8703(86)90481-3. [DOI] [PubMed] [Google Scholar]
  7. Mautner G. C., Mautner S. L., Cannon R. O., 3rd, Hunsberger S. A., Roberts W. C. Clinical factors useful in predicting aortic valve structure in patients > 40 years of age with isolated valvular aortic stenosis. Am J Cardiol. 1993 Jul 15;72(2):194–198. doi: 10.1016/0002-9149(93)90159-a. [DOI] [PubMed] [Google Scholar]
  8. Mautner G. C., Roberts W. C. Reported frequency of coronary arterial narrowing by angiogram in patients with valvular aortic stenosis. Am J Cardiol. 1992 Aug 15;70(4):539–540. doi: 10.1016/0002-9149(92)91206-j. [DOI] [PubMed] [Google Scholar]
  9. Otto C. M., Kuusisto J., Reichenbach D. D., Gown A. M., O'Brien K. D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994 Aug;90(2):844–853. doi: 10.1161/01.cir.90.2.844. [DOI] [PubMed] [Google Scholar]
  10. Peter M., Hoffmann A., Parker C., Lüscher T., Burckhardt D. Progression of aortic stenosis. Role of age and concomitant coronary artery disease. Chest. 1993 Jun;103(6):1715–1719. doi: 10.1378/chest.103.6.1715. [DOI] [PubMed] [Google Scholar]
  11. Rallidis L., Nihoyannopoulos P., Thompson G. R. Aortic stenosis in homozygous familial hypercholesterolaemia. Heart. 1996 Jul;76(1):84–85. doi: 10.1136/hrt.76.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES